European Patent Office

T 2003/08 (Dilated cardiomyopathy/EDWARDS) vom 31.10.2012

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2012:T200308.20121031
Datum der Entscheidung
31. Oktober 2012
Aktenzeichen
T 2003/08
Antrag auf Überprüfung von
-
Anmeldenummer
96941378.0
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden verteilt (C)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
T 2003/08 2012-03-30
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Treatment of dilated cardiomyopathy by removal of autoantibodies
Name des Antragstellers
Edwards Lifesciences Corporation
Reinke, Petra
Brehme, Stefan
Baumann, Gert
Felix, Stephan
Name des Einsprechenden
Fresenius Medical Care Deutschland GmbH
Kammer
3.3.04
Leitsatz
-
Schlagwörter
"Request not to hear a witness due to failure to reply to the invitation in accordance with Rule 118(c) EPC (refused)";
"Request for referral of questions to the Enlarged Board of Appeal (refused)";
Main request: added subject-matter (yes)
Auxiliary request: claims to be interpreted as relating to a second medical use (yes) - means used in the treatment to be considered as a substance or composition in the sense of decision G 5/83; oral disclosure at a lecture - evidence from the lecturer and a member of the audience may be sufficient to establish the oral disclosure - contrary to the application by the first instance of decision T 1212/97; oral disclosure and prior use - established beyond reasonable doubt (no); conformity of the claims with the requirements of the EPC (yes)
Orientierungssatz
see points 6 to 21 and 30 to 48

ORDER

For these reasons it is decided that:

The appeals of both appellants are dismissed.